欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5186/001
药品名称Mykronor 5 micrograms/ml, solution for injection/infusion
活性成分
    • norepinephrine tartrate 10.0 µg/ml
剂型Solution for injection/infusion
上市许可持有人Laboratoire Aguettant 1 Rue Alexander Fleming Lyon 69007 France
参考成员国 - 产品名称Netherlands (NL)
Mykronor 5 microgram/ml, oplossing voor injectie/infusie
互认成员国 - 产品名称
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
      Mykronor
    • Germany (DE)
      Mykronor 5 Mikrogamm/ml, Injektions-/ Infusionslösung
    • Finland (FI)
    • Denmark (DK)
    • Romania (RO)
    • Belgium (BE)
      Mivuxin 5 microgrammes/ml solution injectable/pour perfusion
    • United Kingdom (Northern Ireland) (XI)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
许可日期2021/07/02
最近更新日期2023/11/28
药物ATC编码
    • C01CA03 norepinephrine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase